ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

ClinicalTrials.gov ID: NCT00345774

Public ClinicalTrials.gov record NCT00345774. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Short-Term Efficacy and Safety of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

Study identification

NCT ID
NCT00345774
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Epix Pharmaceuticals, Inc.
Industry
Enrollment
72 participants

Conditions and interventions

Interventions

  • PRX-08066 Drug

Drug

Eligibility (public fields only)

Age range
25 Years to 79 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2006
Primary completion
Not listed
Completion
May 31, 2007
Last update posted
May 28, 2008

2006 – 2007

United States locations

U.S. sites
19
U.S. states
15
U.S. cities
17
Facility City State ZIP Site status
Pinnacle Research Group, LLC Anniston Alabama 36207
Arizona Pulmonary Specialists, Ltd. Phoenix Arizona 85013
University of California-Davis Medical Group Sacramento California 95817
University Clinical Research-DeLand, LLC DeLand Florida 32720
Central Medical Group, PA Tamarac Florida 33321
Clinical Research of West Florida, Inc. Tampa Florida 33603
Atlanta Insitute for Medical Research Decatur Georgia 30030
Pulmonary Consultants of North Idaho Coeur d'Alene Idaho 83814
Loyola University Medical Center Foster McGraw Hospital Maywood Illinois 60153
Veritas Clinical Specialities Topeka Kansas 66606
Tufts New England Medical Center Boston Massachusetts 02111
Massachusetts General Hospital, Pulmonary Critical Care Unit Boston Massachusetts 02114
Buffalo Cardiology and Pulmonary Associates, P.C. Williamsville New York 14221
American Health Research Charlotte North Carolina 28207
South Carolina Pharmaceutical Research Spartanburg South Carolina 29303
Spartanburg Medical Research Spartanburg South Carolina 29303
Baylor College of Medicine Houston Texas 77030
Morgantown Pulmonary Clinical Research Morgantown West Virginia 26505
Heart Care Associates, LLC Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00345774, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 28, 2008 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00345774 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →